Alivus Life Sciences (NSE:ALIVUS) Total Assets : ₹0 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Alivus Life Sciences Total Assets?

Alivus Life Sciences's Total Assets for the quarter that ended in Dec. 2024 was ₹0 Mil.

Warning Sign:

If a company builds assets at 11.7% a year, faster than its revenue growth rate of 10.4% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Alivus Life Sciences's average Total Assets Growth Rate was 4.80% per year. During the past 3 years, the average Total Assets Growth Rate was 11.10% per year. During the past 5 years, the average Total Assets Growth Rate was 11.70% per year.

During the past 6 years, Alivus Life Sciences's highest 3-Year average Total Assets Growth Rate was 12.60%. The lowest was 10.00%. And the median was 11.10%.

Total Assets is connected with ROA %. Alivus Life Sciences's annualized ROA % for the quarter that ended in Dec. 2024 was 17.76%. Total Assets is also linked to Revenue through Asset Turnover. Alivus Life Sciences's Asset Turnover for the quarter that ended in Dec. 2024 was 0.21.

Alivus Life Sciences Total Assets Historical Data

The historical data trend for Alivus Life Sciences's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alivus Life Sciences Total Assets Chart

Alivus Life Sciences Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Assets

Get a 7-Day Free Trial

17,256.04

19,970.75

24,710.07

27,021.47

28,504.12

Alivus Life Sciences Quarterly Data
	Mar19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Assets	Get a 7-Day Free Trial															-	28,504.12	-	30,848.59	-

Alivus Life Sciences Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Alivus Life Sciences's Total Assets for the fiscal year that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (A: Mar. 2024 )	+	Total Liabilities (A: Mar. 2024 )
	=	23323.22	+	5180.9
	=	28,504

Alivus Life Sciences's Total Assets for the quarter that ended in Dec. 2024 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2024 )	+	Total Liabilities (Q: Dec. 2024 )
	=	N/A	+	N/A
	=	N/A

Alivus Life Sciences (NSE:ALIVUS) Total Assets Explanation

Total Assets is connected with ROA %.

Alivus Life Sciences's annualized ROA % for the quarter that ended in Dec. 2024 is

ROA %	=	Net Income (Q: Dec. 2024 )	/	( (Total Assets (Q: Sep. 2024 )	+	Total Assets (Q: Dec. 2024 ))	/ count )
	=	5478.4	/	( (30848.59	+	0)	/ 1 )
	=	5478.4	/	30848.59
	=	17.76 %

Note: The Net Income data used here is four times the quarterly (Dec. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Alivus Life Sciences's Asset Turnover for the quarter that ended in Dec. 2024 is

	Asset Turnover
=	Revenue (Q: Dec. 2024 )	/	( (Total Assets (Q: Sep. 2024 )	+	Total Assets (Q: Dec. 2024 ))	/ count )
=	6418.44	/	( (30848.59	+	0)	/ 1 )
=	6418.44	/	30848.59
=	0.21

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Alivus Life Sciences Total Assets Related Terms

Thank you for viewing the detailed overview of Alivus Life Sciences's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Alivus Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alivus Life Sciences Ltd (NSE:ALIVUS) » Definitions » Total Assets

Traded in Other Exchanges

543322:India

Address

470, Cardinal Gracious Road, 4th Floor, OIA House, Andheri (East), Mumbai, MH, IND, 400 099

Website

https://www.alivus.com

Alivus Life Sciences Ltd, formerly Glenmark Life Sciences Ltd develops, manufactures, and supplies high-quality active pharmaceutical ingredients for cardiovascular disease, central nervous system disease, pain management, diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas.

Alivus Life Sciences Headlines

No Headlines